Alnylam Releases Preclinical Data Showing Efficacy of TTR Amyloidosis Rx Candidate

The company said that it expects to begin clinical testing of the drug in early 2010.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.